Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Quick look at the key results According to clinical trial investigators, orforglipron: Led to significant weight reduction across all dosing groups Showed greater effects at the highest dose levels Helped lower blood sugar in people with diabetes Supported modest improvements in blood pressure Demonstrated mainly mild to moderate side effects The trial results suggest that the once-daily pill performs competitively with early GLP-1 injection studies
Liraglutide ( Saxenda ) A daily injectable GLP-1 medication licensed for weight management
Shukla SD, Sun GY, Gibson Wood W, Savolainen MJ, Alling C, Hoek JB
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
If any of this sounds familiar, talk to your doctor about adjusting your other diabetes medications
"Postprandial antropyloroduodenal motility and gastric emptying in gastroparesiseffects of cisapride"
Contact the Novo Nordisk Patient Assistance Program (PAP) at 1-888-809-3942 to ask about eligibility for financial assistance or medication support programs based on your income and insurance situation
US$ 25.05
US$ 26.00
US$ 23.83
US$ 29.27
US$ 21.57
US$ 26.09
US$ 23.32
